SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-032824
Filing Date
2017-05-15
Accepted
2017-05-15 16:51:02
Documents
84
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8852_110q.htm 10-Q 727704
2 EX-31.1 a17-8852_1ex31d1.htm EX-31.1 10584
3 EX-31.2 a17-8852_1ex31d2.htm EX-31.2 10535
4 EX-32.1 a17-8852_1ex32d1.htm EX-32.1 5638
5 EX-32.2 a17-8852_1ex32d2.htm EX-32.2 6481
  Complete submission text file 0001104659-17-032824.txt   4803613

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ontx-20170331.xml EX-101.INS 883673
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20170331.xsd EX-101.SCH 66377
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20170331_cal.xml EX-101.CAL 36179
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20170331_def.xml EX-101.DEF 243061
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20170331_lab.xml EX-101.LAB 466602
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20170331_pre.xml EX-101.PRE 417536
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 17845169
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1